KARACHI: The Pakistan Medical Association (PMA) has expressed serious concern over the critical shortage of life-saving medicines for heart disease and hepatitis across Pakistan, with Sindh and Punjab facing particularly acute crises. Patients and healthcare providers have reported widespread unavailability of these essential drugs, raising alarms over the potential for severe complications and loss of life. The PMA has condemned the authorities for their negligence in addressing this healthcare emergency, emphasizing that delayed or interrupted treatment could have dire consequences.
The PMA has highlighted that the shortage disproportionately affects vulnerable populations, exacerbating existing health inequalities. It has called on provincial governments to take immediate action to ensure the uninterrupted supply of these vital medications. The association has also stressed the need for a thorough investigation to identify the root causes of the shortage and to implement measures that prevent future occurrences. Strengthening drug regulatory mechanisms and ensuring transparency in the procurement and distribution processes are crucial steps the PMA has recommended to mitigate this crisis.
The PMA remains steadfast in advocating for the rights of patients and has vowed to monitor the situation closely. It has urged all stakeholders, including government authorities, healthcare providers, and regulatory bodies, to work together to resolve the issue and guarantee that all Pakistanis have access to the essential medicines they need to survive.